Prohuman is developing a wearable electromedical device that delivers localized, non-addictive pain relief through targeted electrical stimulation. This technology provides immediate therapeutic benefits at the point of care, addressing the need for effective pain management without reliance on pharmaceuticals.
Funding
$75K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many individuals experience chronic or acute pain that significantly impacts their quality of life. Current pain management strategies often rely on pharmaceutical interventions, which can lead to addiction, side effects, and limited long-term efficacy.
Solution
Prohuman is creating a wearable electromedical device designed to provide localized, non-addictive pain relief through targeted electrical stimulation. The device delivers therapeutic benefits directly at the point of care, offering an alternative to traditional pain management methods. By utilizing electrical stimulation, Prohuman aims to reduce or eliminate the need for pharmaceutical interventions, thereby minimizing the risk of adverse effects and promoting a more sustainable approach to pain relief. This technology seeks to empower individuals to manage their pain effectively and improve their overall well-being.
Target Audience
The primary target audience includes individuals experiencing chronic or acute pain, such as those with musculoskeletal disorders, neuropathic pain, or post-operative pain.
Features
- Wearable design for convenient and discreet use
- Targeted electrical stimulation for localized pain relief
- Non-addictive pain management alternative